期刊
BREAST CANCER
卷 17, 期 1, 页码 9-16出版社
SPRINGER JAPAN KK
DOI: 10.1007/s12282-009-0154-4
关键词
Breast cancer; Sentinel lymph node biopsy (SLNB); Intraoperative false-negative SLNB; Axillary lymph node dissection; Recurrence
资金
- Ministry of Health, Labor and Welfare of Japan
Background It is currently unclear which patients with breast cancer with sentinel lymph node (SLN) metastases do not need axillary lymph node dissection (ALND). Patients and methods A cohort of 1,132 women who had unilateral invasive breast cancer with clinically negative nodes or nodes suspicious for metastasis, were intraoperatively diagnosed as having negative SLNs, and did not undergo an immediate ALND. Our intraoperative histological investigation uses H&E staining of a frozen section from a maximum cut surface of each SLN. Of these 1,132 women, 132 (11.7%) were postoperatively diagnosed as having positive SLNs, which classifies them as having an intraoperative, false-negative SLN biopsy (SLNB). Patient and tumor characteristics, treatment methods, and the prognoses of these patients were investigated and compared with the remaining 1,000 patients who were negative for SLNB. Results Of the 132 patients with intraoperative, false-negative SLNB, none underwent a further ALND. With a median follow-up period of 58.1 months, none of these patients exhibited recurrence in the axillary nodes. Their recurrence-free survival rates were not statistically different from those of patients with negative SLNB. Conclusions ALND can be avoided in most patients with breast cancer with intraoperative, false-negative SLNB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据